top of page
Transaction Support

Transaction Support

Increase the chances of the best possible deal for your company.

Fund Raising and partnering are relatively similar activities from a metholodogy standpoint. 

For start-up companies, fund raising should be personalized by the CEO. Partnering can be delegated to BD personel or consulting support.

In both cases, methodologic support in preparing and / or implementing the exercise is often needed especially for the most early start-up. Having worked with VCs, Big Pharma and start-up companies (both Medtech & Biotech)
e4e6 Consulting team can effectively support CEOs and management teams with fund raising / partnering activities. 

This includes:

  • Partnering / financing “sparing partnership”

  • Communication documents design

  • Due Diligence preparation and support (vendor Due Dil)

  • Investors Outreach and relation monitoring

  • Negotation support

On the buyer side, e4e6 consulting can also provide support to investors / more mature companies in assessing opportunities and complement the company portfolio. This includes:

  • Asset identification

  • Asset landscape assessment

  • Prioritize assets of interest (scope, geography....)

  • Reach out to potential partners

Examples of Assigment:

  • Supported a consortium of major European VCs with commercial assessment in due diligence for Anokion, a Swiss based preclinical Biotech (Series A: CHF 33 Mio). This included “Disease Dossiers” for 4 pathologies, Primary research (US and EU specialists interviews) and Product commercial potential assessment (in various indications) & Indication prioritization.

​​

  • Performed several commercial due diligences for VCs in various therapeutic areas such:

    • Cardiac surgery: Polymer-based technology platform

    • Obesity: New device concept

    • Urology: Connected device (e-health)

    • Oncology: Machine Learning device

​​

  • Ran a full asset screening for pain management including drugs (commercially available and in the development pipeline) as well as medical devices on the behalf of a European mid-size pharma.

bottom of page